Velesco Expands Operations with New Offices in Massachusetts
The new business development office is located in Massachusetts.
Velesco Pharma, a CDMO, has increased its drug formulation, analytical development, and cGMP clinical-trial manufacturing services with the opening of a new business development office in the greater Boston area.
Velesco will be the first life sciences tenant of the Quincy Center for Innovation (QCI), a 12,500 ft2 facility that provides office space and support services to assist start-up companies. The QCI, located in Quincy Massachusetts, is expected to open fully Sept. 1, 2013.
Source: Velesco Pharma
Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries
May 30th 2025In this podcast episode, we discuss novel approaches to drug delivery, specifically regarding adeno-associated virus (AAV) vectors, as viewed by two industry experts who recently exhibited at the annual ASGCT meeting.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
